This systematic scoping review explores the extent and characteristics of research on mobile health (mHealth) interventions for reducing opioid use in chronic pain management. A comprehensive search was run on eight major bibliographic databases (e.g., PubMed) as well as grey literature (e.g., clinical trials registries). Each record was screened by two independent reviewers. Studies were included if they investigated an mHealth intervention for adults with chronic pain and reported opioid use as an outcome (primary or secondary). Data of the study characteristics and results (if available) were extracted and analysed descriptively. Out of 3097 records, 25 (11 published studies, 14 protocols) were included. The studies were from five countries and conducted between 2009-2023. mHealth Interventions included mobile applications (20), text messaging (4), and interactive voice response (1). In about half of the studies (13), taking opioids was an eligibility criterion. In four studies, interventions were specifically designed to support tapering. Studies with published results concluded that the mHealth interventions are acceptable to participants (9) and generally feasible (6). This systematic scoping review shows that there is a growing interest in research investigating mHealth interventions to support people with chronic pain tapering opioids. Current research mostly investigated mobile applications designed for chronic pain management with opioids use as a secondary outcome. mHealth interventions specifically designed to support opioids tapering are emerging. Available results show that mHealth interventions are acceptable, feasible, and potentially efficacious for patients with chronic pain tapering opioids.

The authors have declared no competing interest.

This study did not receive any funding

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes

All data produced in the present study are available upon reasonable request to the authors